General Information of the Protein
Protein ID
PT02129
Protein Name
Leukotriene A-4 hydrolase
Secondarily
Protein Name
Leukotriene A(4) hydrolase
Tripeptide aminopeptidase LTA4H
Gene Name
LTA4H
Secondarily
Gene Name
LTA4
Sequence
MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Metallo protease
>
Metallo protease MAE clan
>
Metallo protease M1 family
Function
Bifunctional zinc metalloenzyme that comprises both epoxide hydrolase (EH) and aminopeptidase activities. Acts as an epoxide hydrolase to catalyze the conversion of LTA4 to the pro-inflammatory mediator leukotriene B4 (LTB4) (PubMed:11917124, PubMed:12207002, PubMed:15078870, PubMed:18804029, PubMed:1897988, PubMed:1975494, PubMed:2244921). Has also aminopeptidase activity, with high affinity for N-terminal arginines of various synthetic tripeptides (PubMed:20813919, PubMed:18804029). In addition to its pro-inflammatory EH activity, may also counteract inflammation by its aminopeptidase activity, which inactivates by cleavage another neutrophil attractant, the tripeptide Pro-Gly-Pro (PGP), a bioactive fragment of collagen generated by the action of matrix metalloproteinase-9 (MMP9) and prolylendopeptidase (PREPL) (PubMed:20813919, PubMed:24591641). Involved also in the biosynthesis of resolvin E1 and 18S-resolvin E1 from eicosapentaenoic acid, two lipid mediators that show potent anti-inflammatory and pro-resolving actions (PubMed:21206090).
    Show/Hide
Uniprot ID
Primary ID:
P09960

Secondarily ID:
B4DNQ9
F8VV40
Q6IAT6
Q9UCT7
    Show/Hide
Ensembl ID
ENSG00000111144
HGNC ID
HGNC:6710
Subcellular Location
Cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000013 , Sf9
Compound ID Compound Name Compound Formula
CP0461979
N-[8-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]ethyl]-8-azabicyclo[3.2.1]octan-3-yl]acetamide
   Show/Hide
C23H26N4O2S
 1
1
IC50 = 0.3 nM
   TI
   LI
   LO
   TS
CP0493620
N-[8-[[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]octan-3-yl]acetamide
   Show/Hide
C22H24N4O2S
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0127823
N-[(1S,5R)-8-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]-8-azabicyclo[3.2.1]octan-3-yl]acetamide
   Show/Hide
C24H24N4O3S
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0428259
2-[4-(2-piperidin-1-ylethyl)phenoxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C19H21N3OS
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0538410
2-[4-(piperidin-1-ylmethyl)phenoxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C18H19N3OS
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0540912
1-[2-[[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]ethanone
   Show/Hide
C21H22N4O2S
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0285661
1-[1-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]piperidin-4-yl]pyrrolidin-2-one
   Show/Hide
C24H24N4O3S
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0285665
N-[1-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]piperidin-4-yl]acetamide
   Show/Hide
C22H22N4O3S
 1
1
IC50 = 3.7 nM
   TI
   LI
   LO
   TS
CP0538409
N-[8-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenoxy]ethyl]-8-azabicyclo[3.2.1]octan-3-yl]acetamide
   Show/Hide
C23H26N4O3S
 1
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
CP0229548
2-[[3-(piperidin-1-ylmethyl)-1-benzofuran-6-yl]oxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C20H19N3O2S
 1
1
IC50 = 4.6 nM
   TI
   LI
   LO
   TS
CP0461978
1-[5-[[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C20H20N4O2S
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0461980
1-[2-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]ethyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]ethanone
   Show/Hide
C22H24N4O2S
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0488516
1-[[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]piperidine-4-carboxamide
   Show/Hide
C19H20N4O2S
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0495589
1-[1-[[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]piperidin-4-yl]pyrrolidin-2-one
   Show/Hide
C22H24N4O2S
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0499756
1-[1-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenoxy]ethyl]piperidin-4-yl]pyrrolidin-2-one
   Show/Hide
C23H26N4O3S
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0461982
1-[2-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenoxy]ethyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]ethanone
   Show/Hide
C22H24N4O3S
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0507762
1-[5-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenoxy]ethyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C21H22N4O3S
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0323958
1-[5-[[5-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-2-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0127970
1-[(1S,4S)-5-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 7.3 nM
   TI
   LI
   LO
   TS
CP0264046
1-[5-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 7.3 nM
   TI
   LI
   LO
   TS
CP0318764
N-[(1S,5R)-8-[[6-(1,3-benzothiazol-2-yloxy)-1-benzofuran-3-yl]methyl]-8-azabicyclo[3.2.1]octan-3-yl]acetamide
   Show/Hide
C25H25N3O3S
 1
1
IC50 = 7.3 nM
   TI
   LI
   LO
   TS
CP0428261
2-[4-(2-piperidin-1-ylethoxy)phenoxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C19H21N3O2S
 1
1
IC50 = 8 nM
   TI
   LI
   LO
   TS
CP0285666
1-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]piperidine-4-carboxylic acid
   Show/Hide
C21H19N3O4S
 1
1
IC50 = 8.3 nM
   TI
   LI
   LO
   TS
CP0127969
1-(1-{2-[4-(1,3-benzothiazol-2-yloxy)phenoxy]ethyl}piperidin-4-yl)pyrrolidin-2-one
   Show/Hide
C24H27N3O3S
 1
1
IC50 = 9.7 nM
   TI
   LI
   LO
   TS
CP0499395
1-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]ethyl]piperidine-4-carboxamide
   Show/Hide
C20H22N4O2S
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0428258
1-[5-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]ethyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C21H22N4O2S
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0461981
1-[1-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]ethyl]piperidin-4-yl]pyrrolidin-2-one
   Show/Hide
C23H26N4O2S
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0120906
1-[[6-(1,3-benzothiazol-2-yloxy)-1-benzofuran-3-yl]methyl]piperidine-4-carboxylic acid
   Show/Hide
C22H20N2O4S
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0461983
1-[2-[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenoxy]ethyl]piperidine-4-carboxamide
   Show/Hide
C20H22N4O3S
 1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0120907
4-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]morpholine
   Show/Hide
C19H17N3O3S
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0301676
N-[1-[[6-(1,3-benzothiazol-2-yloxy)-1-benzofuran-3-yl]methyl]piperidin-4-yl]acetamide
   Show/Hide
C23H23N3O3S
 1
1
IC50 = 26 nM
   TI
   LI
   LO
   TS
CP0507764
6-fluoro-2-[4-(piperidin-1-ylmethyl)phenoxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C18H18FN3OS
 1
1
IC50 = 29 nM
   TI
   LI
   LO
   TS
CP0461984
7-methyl-2-[4-(piperidin-1-ylmethyl)phenoxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C19H21N3OS
 1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
CP0285663
1-[(1S,4S)-5-[[6-(1,3-benzothiazol-2-yloxy)-1-benzofuran-3-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C23H21N3O3S
 1
1
IC50 = 34 nM
   TI
   LI
   LO
   TS
CP0507766
6-chloro-2-[4-(piperidin-1-ylmethyl)phenoxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C18H18ClN3OS
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0193311
2-[[2-(piperidin-1-ylmethyl)-1-benzofuran-6-yl]oxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C20H19N3O2S
 1
1
IC50 = 51 nM
   TI
   LI
   LO
   TS
CP0229547
1-[1-[[6-(1,3-benzothiazol-2-yloxy)-1-benzofuran-3-yl]methyl]piperidin-4-yl]pyrrolidin-2-one
   Show/Hide
C25H25N3O3S
 1
1
IC50 = 58 nM
   TI
   LI
   LO
   TS
CP0239711
1-[5-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-2-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 62 nM
   TI
   LI
   LO
   TS
CP0323959
2-[[2-(piperidin-1-ylmethyl)-1-benzofuran-5-yl]oxy]-[1,3]thiazolo[4,5-b]pyridine
   Show/Hide
C20H19N3O2S
 1
1
IC50 = 66 nM
   TI
   LI
   LO
   TS
CP0159583
2-[[3-(piperidin-1-ylmethyl)-1-benzofuran-6-yl]oxy]-1,3-benzothiazole
   Show/Hide
C21H20N2O2S
 1
1
IC50 = 67 nM
   TI
   LI
   LO
   TS
CP0188288
4-[[6-(1,3-benzothiazol-2-yloxy)-1-benzofuran-3-yl]methyl]morpholine
   Show/Hide
C20H18N2O3S
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0239709
1-[5-[[6-([1,3]thiazolo[5,4-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0155883
2-[[2-(piperidin-1-ylmethyl)-1-benzofuran-5-yl]oxy]-1,3-benzothiazole
   Show/Hide
C21H20N2O2S
 1
1
IC50 = 330 nM
   TI
   LI
   LO
   TS
CP0264047
1-[5-[[5-([1,3]thiazolo[5,4-b]pyridin-2-yloxy)-1-benzofuran-2-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0264048
1-[5-[[5-([1,3]thiazolo[4,5-c]pyridin-2-yloxy)-1-benzofuran-2-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0285662
1-[5-[[6-([1,3]thiazolo[4,5-c]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 340 nM
   TI
   LI
   LO
   TS
CP0301677
2-[[2-(piperidin-1-ylmethyl)-1-benzofuran-6-yl]oxy]-1,3-benzothiazole
   Show/Hide
C21H20N2O2S
 1
1
IC50 = 430 nM
   TI
   LI
   LO
   TS
CP0428262
2-[4-(piperidin-1-ylmethyl)phenoxy]-[1,3]thiazolo[5,4-c]pyridine
   Show/Hide
C18H19N3OS
 1
1
IC50 = 614 nM
   TI
   LI
   LO
   TS
CP0499396
1-[[4-([1,3]thiazolo[5,4-b]pyridin-2-yloxy)phenyl]methyl]piperidine-4-carboxamide
   Show/Hide
C19H20N4O2S
 1
1
IC50 = 733 nM
   TI
   LI
   LO
   TS
CP0440954
2-[4-(piperidin-1-ylmethyl)phenoxy]-[1,3]thiazolo[4,5-c]pyridine
   Show/Hide
C18H19N3OS
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0120905
1-[5-[[6-([1,3]thiazolo[5,4-b]pyridin-2-yloxy)-1-benzofuran-2-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 2130 nM
   TI
   LI
   LO
   TS
CP0127821
1-[5-[[6-([1,3]thiazolo[4,5-c]pyridin-2-yloxy)-1-benzofuran-2-yl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone
   Show/Hide
C22H20N4O3S
 1
1
IC50 = 2370 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0127969
1-(1-{2-[4-(1,3-benzothiazol-2-yloxy)phenoxy]ethyl}piperidin-4-yl)pyrrolidin-2-one
   Show/Hide
C24H27N3O3S
 2
1 IC50 = 16 nM
2 IC50 = 365 nM
CP0285661
1-[1-[[6-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)-1-benzofuran-3-yl]methyl]piperidin-4-yl]pyrrolidin-2-one
   Show/Hide
C24H24N4O3S
 1
1 IC50 = 61 nM
Clinical Information about the Protein
Target 1 ( Leukotriene A-4 hydrolase (LTA4H) )
Target Type Successful Target
Disease 4 Target-related Diseases  4
1 Acute myeloid leukaemia [ICD-11: 2A60]
2 Ulcerative colitis [ICD-11: DD71]
3 Chronic blistering skin disorder [ICD-11: ME63.3]
4 Inflammation [ICD-11: 1A00-CA43.1]
Approved Drug(s) 1 Approved Drug  1
1 Bestatin Approved
Acute myeloid leukaemia
Clinical Trial Drug(s) 2 Clinical Trial Drugs  2
1 LYS006 Phase 2
Ulcerative colitis
2 Acebilustat Phase 1
Chronic blistering skin disorder
Investigative Drug(s) 1 Investigative Drug  1
1 SA-6541 Investigative
Inflammation